"ჰელსიკორი ისრაელი-საქართველოს პირველი ერთობლივი კლინიკაა, რომელიც 2014 წლიდან უზრუნვეყოფს მაღალი ევროპული სტანდარტების სამედიცინო მომსახურებას. კლინიკა აღჭურვილია უახლესი აპარატურით, რაც ჩვენს ექიმებს აძლევს საშუალებას ჩაატარონ უნიკალური პროცედურები და ოპერაციები, რომლებიც საქართველოში ძალიან იშვიათდ ტარდება. ჰელსიკორი თავდაპირველად სპეციალიზირებული კარდიოლოგიური კლინიკა გახლდათ, თუმცა 2020 წელს დაემატა 24-საათიანი სასწრაფო გადაუდებელი სამსახური და ჩამოყალიბდა მრავალპროფილურ სამედიცინო ცენტრად."

During the past decade, LTD Israeli-Georgian Medical Research Clinic Helsicore" conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 7 clinical trials were completed, i.e. on average, 20.6% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 5 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "LTD Israeli-Georgian Medical Research Clinic Helsicore"" #1 sponsor was "Pfizer" with 5 trials, followed by "Celgene" with 3 trials sponsored, "Angion Biomedica Corp" with 2 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "Metavention" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "LTD Israeli-Georgian Medical Research Clinic Helsicore"" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "ADIR, a Servier Group company" with 1 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "Clinical Accelerator" with 1 trials as a collaborator and "Clinical Accelerator (CRO)" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "LTD Israeli-Georgian Medical Research Clinic Helsicore"" are "Hypertension" (4 trials), "Rheumatoid Arthritis" (4 trials), "Ulcerative Colitis" (4 trials), "Crohn Disease" (3 trials) and "Heart Failure" (3 trials). Many other conditions were trialed in "LTD Israeli-Georgian Medical Research Clinic Helsicore"" in a lesser frequency.

Most popular intervention types in "LTD Israeli-Georgian Medical Research Clinic Helsicore"" are "Drug" (27 trials), "Device" (7 trials), "Other" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Etrasimod" (4 trials), "Ozanimod" (3 trials), "OPN-375" (2 trials) and "ALFAPUMP DSR (DIRECT SODIUM REMOVAL) SYSTEM" (1 trials). Other intervention names were less common.

The vast majority of trials in "LTD Israeli-Georgian Medical Research Clinic Helsicore"" are 34 trials for "All" genders.

Currently, there are NaN active trials in "LTD Israeli-Georgian Medical Research Clinic Helsicore"". undefined are not yet recruiting, 13 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in LTD Israeli-Georgian Medical Research Clinic Helsicore", undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in LTD Israeli-Georgian Medical Research Clinic Helsicore", 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".